Eventide Asset Management’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,154,000
| Closed | -$14.6M | – | 148 |
|
|
2022
Q2 | $14.6M | Sell |
1,154,000
-716,000
| -38% | -$9.07M | 0.31% | 82 |
|
|
2022
Q1 | $26.2M | Hold |
1,870,000
| – | – | 0.41% | 74 |
|
|
2021
Q4 | $54.1M | Buy |
1,870,000
+670,000
| +56% | +$19.4M | 0.69% | 45 |
|
|
2021
Q3 | $36M | Hold |
1,200,000
| – | – | 0.47% | 68 |
|
|
2021
Q2 | $31.8M | Hold |
1,200,000
| – | – | 0.43% | 71 |
|
|
2021
Q1 | $37.3M | Buy |
1,200,000
+150,000
| +14% | +$4.66M | 0.55% | 64 |
|
|
2020
Q4 | $34.5M | Buy |
1,050,000
+552,260
| +111% | +$18.2M | 0.53% | 60 |
|
|
2020
Q3 | $17.4M | Buy |
+497,740
| New | +$17.4M | 0.34% | 80 |
|